Phosphatidylcholines: Clinical Trials

14 trials of Phosphatidylcholines, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 withdrawn, 1 active not recruiting, 1 recruiting. 8 Not applicable, 3 Phase 1, 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 6, Active not recruiting 1, Unknown 1
Phase 13Completed 1, Recruiting 1, Withdrawn 1
Phase 33Completed 2, Withdrawn 1
Phase 21Withdrawn 1

Follow Phosphatidylcholines: new trials by email Literature Review of Phosphatidylcholines trials Research Report on Phosphatidylcholines

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development
Placebo, Choline - Child Development, Cannabis Use
Phase 1RecruitingUniversity of Colorado, Denver1402024-11-252025-02-03
Efficacy of Diet on Quality of Life in Multiple Sclerosis
BodyBio Balance Oil, Kirunal Fish Oil, BodyBio PC - Multiple Sclerosis, Relapsing-Remitting
Not applicableActive not recruitingTerry L. Wahls1622022-02-102026-09-18
Impact Of Choline in Patients With NAFLD
Phosphatidyl Choline - Non-Alcoholic Fatty Liver Disease
Not applicableUnknownAin Shams University1002022-02-012022-10-18
Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal
Choline, Placebo - Child Development, Prenatal Stress
Phase 1CompletedUniversity of Colorado, Denver2162017-06-122026-01-07
Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans
Choline Bitartrate, Pre-cooked, pre-peeled whole hardboiled eggs, Egg whites from pre-cooked, pre-peeled hardboiled eggs - Cardiovascular Risk Factor
Not applicableCompletedThe Cleveland Clinic862016-09-022026-07-13
Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune Hepatitis
Paeoniflorin + phosphatidylcholine or silymarin, Phosphatidylcholine or silymarin - Hepatitis, Autoimmune
Phase 3WithdrawnXiaoli Fan2016-08-012017-07-13
Efficacy of Phosphatidylcholine in NAFLD
Phosphatidyl Choline, Lifestyle modification - Non-Alcoholic Fatty Liver Disease
Phase 3CompletedNehal Abou Seada1002016-01-022020-06-04
Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases
Phosphatidylcholine - Hepatic and Hepatobiliary Disorders
Phase 3CompletedSanofi1472015-08-012016-07-04
Dietary Supplementation to Increase Serum Choline Levels
Phosphatidylcholine, Betaine (588 mg qam and 412 mg qpm), Betaine (1000 mg BID) - Healthy
Not applicableCompletedUniversity of Colorado, Denver82015-04-012020-09-02
Phosphatidylcholine Supplementation in Infants
phosphatidylcholine supplementation, placebo - Schizophrenia, Diminished P50 Sensory Gating
Phase 1 / Phase 2WithdrawnUniversity of Colorado, Denver2013-09-012020-09-02
Study to Evaluate the Effect of Injection Lypolysis (Lipodissolve) Treatments to Reduce Body Fat
phosphatidylcholine and deoxycholate - Abdominal Subcutaneous Fat
Not applicableCompletedBodyAesthetic Research Center202008-06-012013-02-07
Supplemental Choline and Brain Development in Humans
Phosphatidylcholine, Corn oil placebo - Healthy
Not applicableCompletedThe Gerber Foundation1502004-12-012010-06-22
Effect of Phosphatidylcholine on Plasma Homocysteine in Healthy Volunteers
supplementation with phosphatidylcholine - Healthy, Cardiovascular Diseases
Not applicableCompletedWageningen Centre for Food Sciences262003-05-012005-06-24
Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency
phosphatidylcholine - Methionine Adenosyltransferase Deficiency, Metabolism, Inborn Errors
Not applicableCompletedNational Center for Research Resources (NCRR)12000-01-012005-06-24

Conditions studied

Non-alcoholic Fatty Liver Disease (2)  ·  Cardiovascular Diseases (1)  ·  Digestive System Diseases (1)  ·  Fatigue (1)  ·  Genetic Diseases, Inborn (1)  ·  Hepatitis, Autoimmune (1)  ·  Hypermethioninemia (1)  ·  Metabolism, Inborn Errors (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Rare Diseases (1)  ·  Schizophrenia (1)

Sponsors

University of Colorado, Denver (4)  ·  Ain Shams University (1)  ·  BodyAesthetic Research Center (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Nehal Abou Seada (1)  ·  Sanofi (1)  ·  Terry L. Wahls (1)  ·  The Cleveland Clinic (1)  ·  The Gerber Foundation (1)  ·  Wageningen Centre for Food Sciences (1)  ·  Xiaoli Fan (1)

Countries

United States (8)  ·  China (1)  ·  Egypt (1)  ·  Netherlands (1)  ·  Russia (1)

Top investigators

Camille Hoffman, MD (2)  ·  Ann Olincy, MD (1)  ·  Doaa Zakaria, PhD (1)  ·  Elizabeth J Brink, PhD (1)  ·  Lamia El Wakeel, PhD (1)  ·  Li Yang, MD (1)  ·  M. Camille Hoffman, MD (1)  ·  Petra Verhoef, PhD (1)  ·  Randal G Ross, MD (1)  ·  Robert Freedman, MD (1)  ·  Sharon Hunter, PhD (1)  ·  Steven H. Zeisel (1)  ·  Terry L Wahls, MD (1)  ·  V. Leroy Young, M.D. (1)

Results publications

PMID 20534746, PMID 23134891, PMID 23439063, PMID 24476345, PMID 27217791, PMID 28394724, PMID 28714183, PMID 29866196, PMID 30050374, PMID 30736445, PMID 30832289, PMID 30871265, PMID 32213121, PMID 32575774, PMID 33872583, PMID 40838115, PMID 41146285

NIH funding

UL1TR001082 (1)